ZYDUSLIFE — Zydus Lifesciences Share News
0.000.00%
- IN₹1.19tn
- IN₹1.30tn
- IN₹271.48bn
Brief: Zydus Lifesciences Says Sentynl Therapeutics Enters Into Agreement With PRG S&T
Brief: Zydus Lifesciences Receives Final Approval From USFDA For Cevimeline Hydrochloride Capsules 30Mg
Brief: Zydus Lifesciences Says Successful Clinical Development Of Pembrolizumab Biosimilar Fyb206
Zydus to launch generic semaglutide injections in India after patent expiry in March
Brief: Zydus Lifesciences Plans To Launch Innovative Semaglutide Injection In India On Day 1 Of Patent Expiry
Brief: Zydus Lifesciences Launches Biosimilar Aflibercept 2 Mg Anyra
Brief: Zydus Lifesciences Receives US FDA Approval For Bosentan Tablets, 32 Mg
India's Zydus agrees $120 million settlement with Astellas over bladder drug (updated)
India's Zydus, US unit settle Mirabegron patent dispute with $120 million payment
Brief: Zydus Lifesciences Enters Settlement Agreement With Astellas Over Myrbetriq
Citi says Lupin-Astellas settlement may delay rival generic launches
India's Zydus Lifesciences set for best session in over a year on quarterly profit beat
India's Zydus Life posts surprise profit rise on strong North American sales
Brief: Zydus Lifesciences Q3 Consol Net Profit 10.42 Billion Rupees
Brief: Zydus Lifesciences Receives Tentative Approval From USFDA For Dapagliflozin Tablets
Brief: Zydus Lifesciences Says USFDA Inspection Closed With 2 Observations For Ankleshwar Unit-2 Plant
Brief: Zydus Lifesciences Launches Biosimilar Of Nivolumab In India
US FDA approves Fortress Bio and Zydus' treatment for a rare pediatric disease (updated)
Brief: FDA Approves First Robenacoxib Tablet For Postoperative Pain In Cats